Childhood obesity

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Iman Djarraya, BMedSci, MBChB, MPH[2]

Synonyms and keywords: obesity in kids, obesity in children, childhood obesity, pediatric obesity

Overview

Childhood obesity is a Body Mass Index (BMI) at or above the 95th percentile for children of the same gender and age. It is a serious health problem that can result in health complications. Childhood obesity can be caused by lifestyle factors, underlying medical conditions, genetic causes or certain medications. It is important to differentiate obesity due to lifestyle factors from obesity due to medications or an underlying medical condition. Obesity in general may present with high blood pressure, insulin resistance, excess facial hair or irregular menstruation. The presence of polyuria and polydipsia suggests possible diabetes, excess facial hair, insulin resistance and irregular menstruation in adolescent girls may be due to polycystic ovary syndrome (PCOS) and dry skin, constipation and intolerance to cold suggest hypothyroidism. laboratory tests indicated depend on the clinical presentation. Management of obesity includes the treatment of any underlying medical conditions and lifestyle modification.

Historical Perspective

• Obesity was first recognized as a medical disorder by Hippocrates, an ancient Greek physician, in 450 B.C..
• In 550 B.C., obesity was linked to heart disease and diabetes by the Indian surgeon Shushruta.
• Obesity rate in the US was first recorded as 13%, in 1962.

Classification

• Childhood obesity may be classified according to BMI-for-age growth chart into two groups:

• Class 1 Obesity: BMI between 100% and 120% of the 95th percentile.
• Severe obesity/class 2or 3 obesity: BMI ≥120% of the 95th percentile or an absolute BMI ≥35 kg/m2 which continues to increase.

Pathophysiology

• The pathogenesis of childhood obesity is characterized by fat accumulation due to energy imbalance.
• This energy imbalance is the result of excess energy intake and/ or decreased energy expenditure.
• It has been suggested that a dysfunction in the ghrelin/leptin hormonal pathway may contribute to abnormal appetite control and increased energy intake.
• Gene mutations in single genes including Leptin (LEP), Leptin Receptor (LEPR), Pro-opio melanocortin (POMC) has been associated with the development of some cases of childhood obesity.

Causes

Childhood obesity may be caused by unhealthy dietary intake, unhealthy lifestyle , environmental factors, psychological factors,genetic causes , an underlying medical condition, medications or hypothalamic obesity.

Dietary intake

Children and adolescents are consuming low nutrient high-calorie foods and beverages at home, school and other places. They are consuming more fast food which is low in nutrients and high in calories, fat and sodium. CDC reports that children and adolescents in the U.S. consumed an average of 13.8% of their daily calories from fast food during 2015-2018. In addition, they are consuming large amounts of sugar-sweetened beverages which has been directly associated with obesity in multiple reviews.

Lifestyle factors

Physical inactivity, excess use of screen time and inadequate sleep also contribute to the obesity epidemic. Eating habits of the child are also affected by demographics, lunch policies at schools and work demands on parents.

Psychological factors

Many children eat in response to stress and or negative emotions such as boredom, anger, sadness, anxiety or depression.

Genetic factors

Often, a child whose parents are overweight or obese will also be overweight or obese. Although this is often caused by shared unhealthy eating habits in the household, several genetic causes have been identified as a cause of obesity. These can be divides into monogenic causes, syndromic obesity and polygenic obesity. Monogenic obesity is caused of a mutation to a single gene including Leptin (LEP) mutations, Leptin Receptor (LEPR) mutations, Pro-opio melanocortin (POMC) mutations, MC4R deficiency, Proconvertase (PC1/2) deficiency, SIM1 deficiency, NTRK2/BDNF mutations and SH2B1 mutations. Syndromic obesity include Prader Willi Syndrome (PWS), Cohen syndrome , Turner syndrome , down syndrome, and Laurence moon biedl syndrome.

Medical conditions

There are hormonal disorders that may be associated with weight gain and obesity in children including: hypothyroidism, cushing's syndrome, growth hormone deficiency, growth hormone resistance, leptin deficiency or resistance to leptin action, polycystic ovary syndrome (PCOS), precocious puberty, prolactin-secreting tumors, and pseudohypoparthyroidism.

Medications

Medications that may cause weight gain in children include cortisol and other glucocorticoids, tricyclic antidepressants, sulfonylureas, monoamine oxidase inhibitors, risperidone, clozapine, oral contraceptives, insulin (in excessive doses) and thiazolidinediones.

Hypothalamic obesity

Weight gain may occur after acquired hypothalamic lesions following surgery, cranial radiation or diencepahlic tumors. It can also be a result of cranial trauma or inflammation of the hypothalamus.

Differentiating childhood obesity due to lifestyle factors from other Diseases

• Childhood obesity due to lifestyle factors must be differentiated from other diseases that cause obesity, high blood pressure, and insulin resistance such as:

• Hypothyroidism
• Cushing syndrome
• Diabetes
• Polycystic ovary syndrome (PCOS)

Epidemiology and demographics

• The prevalence of children who are overweight or obese worldwide is approximately 38 million in children under the age of 5 in 2019 and more than 340 million between 5 and 19 years old in 2016.

• In 2015-2016, the prevalence of Childhood Obesity among children aged 2-19 years was estimated to be 13.7 million cases (18.5%) in USA.

Age

• Children of all age groups may develop Childhood Obesity.
• Childhood Obesity is more commonly observed among children aged 12 to 19 years old in the USA. This is followed by children aged 6 to 11 years old and then children aged 2 to 5 years of age.

Gender

• Childhood Obesity prevalence by gender is different depending on the region.
• Males are more commonly affected than females 5 to 19 years of age in most high and upper middle-income countries.

Race

• There are racial differences for obesity in children.

• Obesity prevalence was higher among Hispanics and non-Hispanic blacks than non-Hispanic whites and non-Hispanic Asians.

Risk Factors

• Common risk factors in the development of Childhood obesity are high calorie diet, lack of physical activity, children who have obese family members, stress and low-income households.

Natural History, Complications and Prognosis

• If left untreated, patients with childhood obesity may progress to develop glucose intolerance, type 2 diabetes, high blood pressure, high cholesterol, asthma, obstructive sleep apnea, non-alcoholic fatty liver, gall stones,joint pain and depression.
• Common complications of childhood obesity include the progression to adult obesity and increased risk of heart disease, diabetes and cancer risk.
• Obese children often suffer from weight stigma, teasing and bullying amongst their peers. They experience descrimination in the society. They are more likely to suffer from low self esteem, anxiety and depression.

Diagnosis

Diagnostic Criteria

• The diagnosis of childhood obesity is made when the calculated Body Mass Index (BMI) is at or above the 95th percentile on the BMI-for-age growth chart.

History and Symptoms

• Symptoms of childhood obesity may include the following:

• shortness of breath
• sleep apnea
• constipation
• gastroesophageal reflux
• irregular menstruation

Physical Examination

• Physical examination may be remarkable for:

• stretch marks on hips and abdomen
• acanthosis nigricans
• dry skin and fatigability may be signs of hypothyroidism.
• purple striae and accumulation of fat in the neck and trunk may suggest cortisol excess.
• signs of early sexual development may be a sign of precocious puberty.
• acne and excess facial hair may suggest cortisol excess or polycystic ovary syndrome.

Laboratory Findings

• Children with BMI 85 or more require fasting blood glucose, fasting lipid panel, ALT, AST and serum hemoglobin A1C or 2-hour glucose tolerance test.
• The following tests may be indicated for children with obesity depending on the clinical presentation:

• Thyroid function tests
• Adrenal function tests
• Liver function tests
• Serum leptin
• Serum calcium, phosphorus and parathyroid hormone
• Growth hormone
• Reproductive hormones

Treatment

Medical therapy

• Management of obesity in children focuses on reducing BMI of the child safely, preventing and managing complications.
• The mainstay of therapy for obesity in children is diet and exercise.
• Setmelanotide, a melanocortin-4-receptor agonist was approved by the U.S. Food and Drug Administration (FDA) for children age 6 and older with obesity caused by rare genetic disorders.

Surgery

• Bariatric surgery are performed in some adolescents with severe obesity.

Prevention

• There are multiple preventive measures available for childhood obesity
• Effective measures for the primary prevention of childhood obesity include exclusive breast feeding for the first 6 months of life, consumption of fruits and vegetables, drinking water, restriction of sweetened drinks and sugary snacks, regular physical activity, limiting screen time, reducing stress, and providing a healthy sleep routine.

See also

• Hereditary factors in childhood obesity

External links

• Mayo clinic article on preventing childhood obesity